Evolution of resistance to Aurora kinase B inhibitors in leukaemia cells.
Failes TW, Mitic G, Abdel-Halim H, Po'uha ST, Liu M, Hibbs DE, Kavallaris M.
Failes TW, et al.
PLoS One. 2012;7(2):e30734. doi: 10.1371/journal.pone.0030734. Epub 2012 Feb 16.
PLoS One. 2012.
PMID: 22359551
Free PMC article.
Human T-cell acute lymphoblastic leukaemia cells, CCRF-CEM, were selected for resistance in 4 M ZM447439. CEM/AKB4 cells showed no cross-resistance to tubulin-targeted and DNA-damaging agents, but were hypersensitive to an Aurora kinase A inhibitor. ...Progression of resi …
Human T-cell acute lymphoblastic leukaemia cells, CCRF-CEM, were selected for resistance in 4 M ZM447439. CEM/AKB4 cells showed no c …